glp -1 agonist A Closer Look at the Dermatological Profile of GLP-1 Agonists A Closer Look at the

It helps maintain gut health, support metabolic performance, and promote immune and internal balance over time.

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors

ICD-10 codes to identify the outcome are included in supplementary table S1

Within the first seven days, youll feel it working!*